Rothwell, Figg, Ernst & Manbeck, P.C.

Ongoing Funding in AI-powered Drug Discovery Highlights Future Importance of Inventorship in Biosimilar Legal Disputes | Notable Law Firm

There’s something buzzing in the pharmaceutical industry’s pot, and it’s not just the caffeine in our favorite bodega brew. On the crispy morning of December 3, 2024, Bristol Myers Squibb, a heavyweight in the drug-discovering arena, decided to dance with a young, dashing startup, AI Proteins, in what may feel like a cacophony of test […]